DES and neoplasm: Undetermined tumours should be subjected to further immunohistochemistry, such as analysis of smooth-muscle actin, desmin, vimentin, von Willebrand factor or neuron-specific enolase, before a final diagnosis of “poorly differentiated sarcoma” should be made.